Department of Rheumatology, Boston University School of Medicine, Boston, MA, USA; University of Manchester and the NIHR Manchester Musculoskeletal Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Osteoarthritis Cartilage. 2021 Jul;29(7):973-978. doi: 10.1016/j.joca.2021.03.006. Epub 2021 Mar 20.
Inflammation worsens joint destruction in osteoarthritis (OA) and aggravates pain. Saturated and n-6 fatty acids (FAs) increase, whereas n-3 FAs reduce inflammation. We examined whether FA levels affected the development of OA.
We studied participants from the Multicenter Osteoarthritis study (MOST) at risk of developing knee OA. After baseline, repeated knee x-rays and MRIs were obtained and knee symptoms queried through 60 month follow-up. Using baseline fasting samples, serum FAs were analyzed with standard assays. After excluding participants with baseline OA, we defined two sets of cases: those developing radiographic OA and those developing symptomatic OA (knee pain and radiographic OA). Controls did not develop these outcomes. Additionally, we examined worsening of MRI cartilage loss and synovitis and of knee pain using WOMAC and evaluated the number of hand joints affected by nodules. In regression models, we tested the association of each OA outcome with levels of saturated, n-3 and n-6 FAs adjusting for age, sex, BMI, education, race, baseline pain and depressive symptoms.
We studied 260 cases with incident symptomatic and 259 with incident radiographic OA. Mean age was 61 years (61% women). We found no signficant nor suggestive associations of FA levels with incident OA (e.g., for incident symptomatic OA, OR per s.d. increase in n-3 FA 1.00 (0.85, 1.18) nor with any OA outcome in knee or hand.
Despite previously described effects on systemic inflammation, blood levels of FAs were not associated with risk of later knee OA or other OA outcomes.
炎症会加重骨关节炎(OA)的关节破坏,并加重疼痛。饱和脂肪酸(FAs)和 n-6 脂肪酸增加,而 n-3 FAs 则减少炎症。我们研究了 FA 水平是否会影响 OA 的发展。
我们研究了多中心骨关节炎研究(MOST)中处于发生膝骨关节炎风险的参与者。基线后,进行了重复的膝关节 X 光和 MRI,并通过 60 个月的随访询问膝关节症状。使用基线空腹样本,采用标准检测方法分析血清 FA。排除基线 OA 患者后,我们定义了两组病例:发生放射学 OA 和发生症状性 OA(膝关节疼痛和放射学 OA)的病例。对照组未发生这些结局。此外,我们还通过 WOMAC 评估了 MRI 软骨损失和滑膜炎以及膝关节疼痛的恶化情况,并评估了受结节影响的手部关节数量。在回归模型中,我们通过调整年龄、性别、BMI、教育程度、种族、基线疼痛和抑郁症状,测试了每种 OA 结局与饱和、n-3 和 n-6 FAs 水平的关联。
我们研究了 260 例新发症状性 OA 和 259 例新发放射学 OA 病例。平均年龄为 61 岁(61%为女性)。我们没有发现 FA 水平与新发 OA 之间存在显著或提示性关联(例如,对于新发症状性 OA,n-3 FA 每增加 1 个标准差,OR 为 1.00(0.85,1.18),与膝关节或手部的任何 OA 结局均无关。
尽管之前描述了 FA 对系统性炎症的影响,但血液 FA 水平与随后发生膝骨关节炎或其他 OA 结局的风险无关。